Angi (ANGI) shares were down about 6% in recent Wednesday trading after Goldman Sachs and Citigroup downgraded the stock following its Q3 results.
Goldman Sachs downgraded the stock to neutral from buy and cut its price target to $2.50 from $3.25. Citigroup also lowered Angi to neutral from buy.
Other analysts cut their price targets, with RBC to $2.75 from $3.25 and UBS to $2.40 from $2.80.
Trading volume stood at about 1.2 million shares against a daily average of roughly 546,000.
Price: 1.82, Change: -0.12, Percent Change: -5.96
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.